{"cluster": 32, "subcluster": 8, "abstract_phrases": [{"text": "squamous cell lung cancer", "rank": 0.071}, {"text": "squamous cell lung carcinoma", "rank": 0.069}, {"text": "squamous cell carcinoma", "rank": 0.068}, {"text": "cbdca)plus pembrolizumab chemotherapy", "rank": 0.066}, {"text": "pembrolizumab maintenance chemotherapy", "rank": 0.065}], "title_phrases": [{"text": "squamous cell lung cancer", "rank": 0.125}, {"text": "her2-positive gastric cancer", "rank": 0.118}, {"text": "pancreatic neuroendocrine carcinoma", "rank": 0.112}, {"text": "treated", "rank": 0.107}, {"text": "metastatic mismatch repair", "rank": 0.106}], "title_abstract_phrases": [{"text": "squamous cell lung cancer", "rank": 0.074}, {"text": "squamous cell lung carcinoma", "rank": 0.07}, {"text": "squamous cell carcinoma", "rank": 0.07}, {"text": "combined s-1/trastuzumab chemotherapy", "rank": 0.066}, {"text": "cbdca)plus pembrolizumab chemotherapy", "rank": 0.064}]}